Header Logo

Connection

JOHN LYDON to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications JOHN LYDON has written about Drug Resistance, Neoplasm.
JOHN LYDON
Connection Strength
0.085
Drug Resistance, Neoplasm
  1. Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance. Neoplasia. 2014 May; 16(5):390-402.
    View in: PubMed
    Score: 0.085
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.